Sandbox: jss: Difference between revisions

VisualWikitext

Revision as of 00:21, 8 July 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Potassium >5.1meq/L

ECG

If no changes,rule out pseudohyperkalemia

If changes present then start urgent treatment

Urine sodium <25 meq/L

urine sodium >25 meq/L

ARF
CKD
Heart failure
Volume depletion

Decreased K+secretion(Urine K+<20meq/L

Transcellular shift(measure serum osmolarity and pH)

Low aldosterone(TTG<3)

Normal aldosterone(TTG>7)

Diabetic ketoacidosis
Metabolic acidosis

Low renin

Normal renin

Tissue breakdown
Pseudohypoaldosternism type 1 and type 2
Type 1 RTA

Interstital nephritis
Obstructive uropathies
Diabetic nephropathy
ACE inhibitors,Angiotensin 2 receptors

Primary hypoaldosteronism
Congenital adrenal hyperplasia
Aldosterone receptor antagonists
RTA type 4

@@ Line 4: / Line 4: @@
+{{Family tree/start}}
-{{familytree/start |summary=PE diagnosis Algorithm.}}
+{{Family tree | | | | | | | | | | | | | | A01 | | | | | | | | | | | |A01=Potassium >5.1meq/L}}
-{{familytree | | | | | | | | | | A01 | | | | |A01=Serum Potassium >5.1meq/L}}
+{{Family tree | | | | | | | | | | | | | | |!| | | | | | | | | | | | }}
-{{familytree | | | | | | | | | | |!| | | | | | | }}
+{{Family tree | | | | | | | | | | | | | | B01 | | | | | | | | | | | B01= ECG }}
-{{familytree | | | | | | | | | | A02 | | | | | |A02=Measure GFR}}
+{{Family tree | | | | | | | | | | | | |,|-|^|-|.| | | | | | | | | | }}
-{{familytree | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | }}
+{{Family tree | | | | | | | | | | | | C01 | | C02 | | | | | | | | | C01=If no changes,rule out pseudohyperkalemia| C02= If changes present then start urgent treatment}}
-{{familytree | | | B01 | | | | | | | | | | | | | B02 | | |B01=GFR <15ml/min/1.73m2|B02=GFR>15ml/min/1.73m2}}
+{{Family tree | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | | | |}}
-{{familytree | | | |!| | | | | | | | | | | | | | |!| | | | }}
+{{Family tree | | | | | | | D01 | | | | | | | D02 |D01=Urine sodium <25 meq/L|D02=urine sodium >25 meq/L }}
-{{familytree | | | C01 | | | | | | | | | | | | | |!| |C01=Measure urinary potassium|C02=Measure Aldosterone}}
+{{Family tree | | | | | | | |!| | | |,|-|-|-|-|^|-|-|-|-|.| | | | | }}
-{{familytree | |,|-|^|-|.| | | | | | | | |,|-|-|-|+|-|-|-|.| | }}
+{{Family tree | | | | | | | E01 | | E02 | | | | | | | | E03 | | | | | | | E01=ARF<br>CKD<br>Heart failure<br>Volume depletion|E02=Decreased K+secretion(Urine K+<20meq/L|E03=Transcellular shift(measure serum osmolarity and pH) }}
-{{familytree | |!| | | |!| | | | | | | | |!| | | |!| | | |!| | }}
+{{familytree  | | | | | | |,|-|-|-|-|^|-|-|.| | | | | | |!| | | | | | | | }}
-{{familytree | D01 | | D02 | | | | | | | D03| | |D04 | | D05| |D01=Urine potassium <20meq/L|D02=urine potassium >125meq/L|D03=Aldosterone low|D04=Aldosterone normal\high}}
+{{Family tree | | | | | | F01 | | | | | | F02 | | | | | F03 | | | | | | F01=Low aldosterone(TTG<3)|F02=Normal aldosterone(TTG>7)|F03=Diabetic ketoacidosis<br>Metabolic acidosis}}
-{{familytree | |!| | | |!| | | | | | | | |!| | | |!| | | | }}
+{{Family tree | | | | |,|-|^|-|.| | | | | |!| | | | | | | | | | | }}
-{{familytree | E01 | | E02 | | | | | | | E03 | | E04 | | | |E01=*Acute renal failure<br>Chronic renal failure<br>Heart failure<br>Volume depletion<br>Tissue breakdown<br>*Blood transfusion|E02=Supplemental potassium|E03=Measure renin|E04=Pseudohypoaldostrenism type 1 and type 2<br>Aldosterone receptor antagonist<br>Amiloride<br>Sprironolactone<br>Type 1 RTA }}
+{{Family tree | | | | G01 | | G02 | | | | G03 | | | | | | | | | | G01=Low renin|G02=Normal renin|G03=Tissue breakdown<br>Pseudohypoaldosternism type 1 and type 2<br>Type 1 RTA }}
-{{familytree | | | | | |!| | | | | | | | | | |!| | | |!| | | | }}
+{{Family tree | | | | |!| | | |!| | | | | | | | | | | | }}
-{{familytree | | | | | | | | | | | | | | | | |!| | }}
+{{Family tree | | | | H01 | | H02 | | | | | | | | | H01=Interstital nephritis<br>Obstructive uropathies<br>Diabetic nephropathy<br>ACE inhibitors,Angiotensin 2 receptors|H02=Primary hypoaldosteronism<br>Congenital adrenal hyperplasia<br>Aldosterone receptor antagonists<br>RTA type 4
-{{familytree | | | |,|-|^|-|.| | | | | | |,|-|^|-|.| |!| | }}
+}}
-{{familytree | | | G01 | | G02 | | | | | G03 | | | | G04 |!| | |G01=G01|G02=G02|G03=Renin low|G04=Renin normal/high}}
-{{familytree | | | |!| | | |!| | | | | | |!| | | |,|-|^|-|v|-|-|.|}}
-{{familytree | | | H01 | | H02 | | | | | H03 | | H04 | | H05 | | H06 |H01=H01|H02=H02|H03=Hyporenimic Hypoaldosteronism|H04=Primary hypoaldosteronism<br>Congenital adrenal hyperplasia<br>Secondary hypoaldosteronism<br>Drugs|H05=High serum osmolarity<br>Diabteic Ketoacidosis|H06=Metabloic acidosis}}
-{{familytree | | | |!| | | | | | | | | | |!| | | |!| | | | | }}
-{{familytree | | | I01 | | | | | | | | | I02 | | I03 | | | |I01=I01|I02=Interstitial nephritis<br>Obstructive uropathy<br>ACE inhibitors<Angiotensin 2 receptor antagonists |I03=}}
-{{familytree | |,|-|^|-|.| | | | | | | | |!| |,|-|^|-|.| | | |}}
-{{familytree | J01 | | J02 | | | | | | | |!| J03 | | J04 | | | |J01=J01|J02=J02|J03=J03|J04=J04}}
-{{familytree | |!| | | | | | | | | | | | |!| |!| | | |!| | |}}
-{{familytree | K01 |-|-|-|-|-|-|-|-|-|-|-|'| |!| | | K02 | |K01=K01|K02=K02}}
-{{familytree | |!| | | | | | | | | | | | | | |!| | | | | | |}}
-{{familytree | |`|-|-|-|-|-|-|-|-|-|-|-|-|-|-|'| | | | | | |}}
-{{familytree/end}}

Sandbox: jss: Difference between revisions

Revision as of 00:21, 8 July 2018

Navigation menu